Literature DB >> 1592182

The effects of formulation and moisture on the stability of a freeze-dried monoclonal antibody-vinca conjugate: a test of the WLF glass transition theory.

M L Roy1, M J Pikal, E C Rickard, A M Maloney.   

Abstract

Deacetylvinblastine (DAVLB) hydrazide, a cytotoxic vinca alkaloid, has been linked to the monoclonal antibody, KS1/4, via aldehyde residues of the oxidized carbohydrate groups on the antibody. The resulting KS1/4-DAVLB hydrazide conjugate is unstable in solution with both the acyl hydrazone linkage and the vinca moiety being subject to significant degradation, even at 5 degrees C. This necessitated the development of a freeze-dried formulation of the antibody-drug conjugate. Formulation factors considered were pH, ionic strength, buffer, excipient types, and excipient ratios. A formulation with equal weight ratios of mannitol, glycine, and conjugate in a low ionic strength phosphate buffer at near neutral pH was selected. Stability was studied at various moisture levels (1.4%, 3.0%, and 4.7%) and temperatures (5 degrees C, 25 degrees C, and 40 degrees C). Degradation was measured by size exclusion HPLC (aggregate formation) and by reverse phase HPLC (hydrolysis of hydrazone linkage and vinca decomposition). Differential scanning calorimetry (DSC) indicated that all samples were above their glass transition temperatures, Tg, when stored at 40 degrees C. When stored at 25 degrees C, only the highest moisture sample was initially above its Tg. However, due to crystallization of the excipients during storage and the resulting decrease in Tg, samples stored at 25 degrees C were also above their Tg during much of the storage period. The degradation rate, R, increased sharply with increasing temperature and with increasing moisture level. Degradation kinetics obeyed the Williams-Landel-Ferry relationship, R/Rg = exp[k(T-Tg)], where Rg is the degradation rate at Tg. For all three moisture levels and all three degradation pathways, k = 0.143.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1592182

Source DB:  PubMed          Journal:  Dev Biol Stand        ISSN: 0301-5149


  11 in total

1.  Effect of moisture on the stability of a lyophilized humanized monoclonal antibody formulation.

Authors:  E D Breen; J G Curley; D E Overcashier; C C Hsu; S J Shire
Journal:  Pharm Res       Date:  2001-09       Impact factor: 4.200

2.  Development of a stable freeze-dried formulation of recombinant human interleukin-1 receptor antagonist.

Authors:  B S Chang; G Reeder; J F Carpenter
Journal:  Pharm Res       Date:  1996-02       Impact factor: 4.200

3.  Real-time in situ monitoring of lysozyme during lyophilization using infrared spectroscopy: dehydration stress in the presence of sucrose.

Authors:  R L Remmele; C Stushnoff; J F Carpenter
Journal:  Pharm Res       Date:  1997-11       Impact factor: 4.200

4.  Measurement of glass transition temperatures of freeze-concentrated solutes by differential scanning calorimetry.

Authors:  L M Her; S L Nail
Journal:  Pharm Res       Date:  1994-01       Impact factor: 4.200

5.  Effect of glass transition temperature on the stability of lyophilized formulations containing a chimeric therapeutic monoclonal antibody.

Authors:  S P Duddu; P R Dal Monte
Journal:  Pharm Res       Date:  1997-05       Impact factor: 4.200

6.  Solid-state stability of human insulin. I. Mechanism and the effect of water on the kinetics of degradation in lyophiles from pH 2-5 solutions.

Authors:  R G Strickley; B D Anderson
Journal:  Pharm Res       Date:  1996-08       Impact factor: 4.200

Review 7.  Stabilization of proteins in solid form.

Authors:  Marcus T Cicerone; Michael J Pikal; Ken K Qian
Journal:  Adv Drug Deliv Rev       Date:  2015-05-14       Impact factor: 15.470

8.  Towards preserving the immunogenicity of protein antigens carried by nanoparticles while avoiding the cold chain.

Authors:  Brian R Sloat; Michael A Sandoval; Zhengrong Cui
Journal:  Int J Pharm       Date:  2010-04-21       Impact factor: 5.875

9.  The effect of excipients on the molecular mobility of lyophilized formulations, as measured by glass transition temperature and NMR relaxation-based critical mobility temperature.

Authors:  S Yoshioka; Y Aso; S Kojima
Journal:  Pharm Res       Date:  1999-01       Impact factor: 4.200

10.  Surface denaturation at solid-void interface--a possible pathway by which opalescent particulates form during the storage of lyophilized tissue-type plasminogen activator at high temperatures.

Authors:  C C Hsu; H M Nguyen; D A Yeung; D A Brooks; G S Koe; T A Bewley; R Pearlman
Journal:  Pharm Res       Date:  1995-01       Impact factor: 4.200

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.